<DOC>
	<DOCNO>NCT02179138</DOCNO>
	<brief_summary>To assess acceptability user-filled , paper , applicator delivery tenofovir ( TFV ) gel among woman high risk acquire human immunodeficiency virus ( HIV ) rural KwaZulu-Natal , South Africa .</brief_summary>
	<brief_title>Paper Applicator Acceptability Study</brief_title>
	<detailed_description>CAPRISA 070 design enroll rural woman exit CAPRISA 008 - ongoing trial assess implementation , effectiveness safety TFV gel KwaZulu-Natal , South Africa . All study participant CAPRISA 008 also participate CAPRISA 004 thus several year experience use TFV gel prefilled , plastic applicator . CAPRISA 070 allow u assess acceptability user-filled , paper applicator among woman extensive experience pre-filled , plastic applicator well-positioned provide feedback comparison new gel delivery method .</detailed_description>
	<criteria>Age 18 year old Women previously participate CAPRISA 008 Able willing provide first person inform consent screen , enroll , study Allow access CAPRISA 008 data , include study exit data Able willing provide adequate locator information study retention purpose Sexually active ( least one coital act last 3 month prior screen ) HIV negative Negative pregnancy test * Agree use nonbarrier form contraceptive Agree adhere study visit procedure breastfeed exclusionary participant must inform presence TFV breast milk negligible amount Has creatinine clearance , &lt; 50ml/min , estimate use method Cockcroft Gault Has condition , base opinion investigator designee would preclude provision inform consent , make participation study unsafe , complicate interpretation study outcome data , otherwise interfere achieve study objective</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>